Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(18/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(18/week)
News
United States
(572/week)
Manufacturing
(420/week)
Energy
(315/week)
Technology
(459/week)
Other Manufacturing
(342/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Nivolumab
Sep 26, 2019
Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Triple-Negative Breast Cancer Patients at the 2019 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Sep 19, 2019
Partner Therapeutics Receives Orphan Drug Designation for Leukine® (sargramostim)
Sep 19, 2019
Compugen Presents Update on COM701 Phase 1 Study at 2019 IGCS
Sep 10, 2019
KEYNOTE-024 Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
Aug 06, 2019
Dragonfly Therapeutics Adds World-Leading Cancer Immunotherapy Pioneer to its Scientific Advisory Board
Aug 02, 2019
Global Orphan Drugs Market 2019-2024 - Major Players are Teva Pharmaceutical, Celgene, Merck & Co, Bristol-Myers Squibb Co, and F. Hoffmann-La Roche
Jul 10, 2019
TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo® (nivolumab) for Patients with Muscle-Invasive Bladder Cancer
Jun 05, 2019
Oncology Immune-Checkpoint Drugs Analytical Tool
Jun 03, 2019
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting
Jun 01, 2019
Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting
May 29, 2019
Infinity Pharmaceuticals To Present At The 2019 BIO International Convention
May 21, 2019
Debiopharm Expands its Immuno-Oncology Development Program for Debio 1143, with the First IAP Inhibitor/Nivolumab Combination Trial
May 20, 2019
Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid Tumors
May 14, 2019
Global and China Monoclonal Antibody Market 2019-2025: Roche, Johnson & Johnson, Merck, Novartis, AbbVie and Amgen Dominate the Market
Apr 29, 2019
Mirati Therapeutics Reports First Quarter 2019 Financial Results
Apr 23, 2019
OncoSec Announces Triple Combination Immunotherapy Clinical Trial Of TAVO(TM), Epacadostat And KEYTRUDA® In Squamous Cell Head And Neck (SCCHN) Cancer
Apr 02, 2019
With Safety Analysis Complete, Roswell Park Moves Forward With Expanded Study of CIMAvax
Apr 01, 2019
Apexigen Presents Clinical Data On CD40 Antibody APX005M In Metastatic Melanoma At The AACR Annual Meeting 2019
Apr 01, 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Mar 31, 2019
Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019
‹‹
Page 2
››
Latest News
May 2, 2024
EnerSys Announces Date of Fourth Quarter and Full Year Fiscal 2024 Financial Results Release and Conference...
May 2, 2024
Eversource Energy Reports First Quarter 2024 Results
May 2, 2024
ATS to Participate in TD Cowen’s 2nd Annual Sustainability Conference
May 2, 2024
Distribution Solutions Group’s Operating Company, Lawson Products, Executes a Strategic Acquisition of S&...
May 2, 2024
Novanta to Present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday,...
May 2, 2024
CF Industries Holdings, Inc. Reports First Quarter 2024 Net Earnings of $194 Million, Adjusted EBITDA of $459...
May 2, 2024
Iowa American Water Files Rate Request Driven by Over $157 Million in Investment
May 2, 2024
From Kibbles to Fresh Food, AGI Introduces Tailored Solutions for Pet Food Manufacturing
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events